Article Details

Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite

Retrieved on: 2021-09-07 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite. View article details on hiswai:

Excerpt

There are at least seven bispecific monoclonal antibodies in the race to reach the relapsed or refractory multiple myeloma market. Efficacy and safety class ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up